A Study to Assess the Persistence of Two GBS Antibodies in Women Previously Immunized With a GBS Vaccine

Clinical trial NCT01053767 · COMPLETED

Trial details

NCT number: NCT01053767
Sponsor: Novartis Vaccines
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Group B Streptococcus (GBS) Disease

Start date: 2010-01-01
Primary completion: 2010-08-01
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.